Startups

Mission Therapeutics discovers and develops selective inhibitors for deubiquitylating enzymes.

Developing targeted therapeutics to arrest the progression of degenerative diseases.

MoA Technology develops next-generation herbicides to combat global weed resistance.

Mogrify develops in vivo reprogramming therapies to transform patient outcomes in degenerative diseases.

Monument Therapeutics develops stratified treatments for central nervous system conditions using digital brain biomarkers.

Mosaic Therapeutics develops targeted oncology treatments using advanced computational methods and cancer genomics.

MultiplAI Health develops universal precision screening technology for cardiovascular and complex diseases using genomic data and artificial intelligence.

Multus Media develops growth media for the cultivated meat industry.

Mykor creates low-carbon construction materials using agricultural and industrial waste.

Mytos builds automated production systems for human cell manufacturing.